Loading…
Insulet Corporation is projected to rise to $181.24 by 2027, a +12% move from its current price of $161.16. PODD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $157.39 | $161.23 | $165.16 | +0.05% |
| Jul 13 | $155.89 | $161.30 | $166.90 | +0.09% |
| Jul 14 | $154.78 | $161.38 | $168.26 | +0.14% |
| Jul 15 | $153.85 | $161.45 | $169.43 | +0.18% |
| Jul 16 | $153.05 | $161.53 | $170.48 | +0.23% |
| Jul 17 | $152.33 | $161.60 | $171.44 | +0.28% |
| Jul 18 | $151.68 | $161.68 | $172.33 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $151.68 | $161.68 | $172.33 | +0.32% |
| Week 2 | $148.20 | $162.20 | $177.52 | +0.65% |
| Week 3 | $145.70 | $162.72 | $181.74 | +0.97% |
| Week 4 | $143.69 | $163.25 | $185.47 | +1.30% |
| Week 5 | $142.00 | $163.77 | $188.89 | +1.63% |
| Week 6 | $140.53 | $164.30 | $192.10 | +1.95% |
| Week 7 | $139.23 | $164.83 | $195.15 | +2.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.
The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
PODD is the Insulet Corporation stock trading in Healthcare. It currently fetches a price of $159.79 per share, with a market cap of $11.07B and a market rank of 880. The stock sits in the Healthcare category.
A major floor 19.7% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.1% away) — a breakout level to watch.
A major ceiling 50.7% above — clearing it would confirm fresh momentum.
Key PODD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PODD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $159.67 | Buy | $159.60 | Buy |
| MA 10 | $159.09 | Buy | $157.97 | Buy |
| MA 20 | $153.02 | Buy | $155.70 | Buy |
| MA 50 | $153.76 | Buy | $162.46 | Sell |
| MA 100 | $187.24 | Sell | $186.20 | Sell |
| MA 200 | $243.54 | Sell | $219.67 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.63 | Neutral |
| Stoch RSI (14) | 83.17 | Sell |
| CCI (20) | 88.49 | Neutral |
| Williams %R (14) | -12.54 | Info |
| MACD (12,26,9) | 1.45 | Buy |
| ROC (12) | 12.08 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 87.46 | Sell |
| TRIX (15) | 0.04 | Buy |
| Awesome (5,34) | 8.06 | Buy |
| Ultimate (7,14,28) | 64.55 | Neutral |
| Momentum (10) | 7.46 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 159.34 | Buy |
| ADX (14) | 15.22 | Neutral |
| ATR (14) | 3.76 | Info |
The current price sits near technical levels with a 30-day range of $134.17 to $190.30. The RSI14 is 60, and the price is above the SMA50 of $157.28 while the SMA200 stands at $248.70. Nearby support is listed at $138.97 and resistance at $159.79.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $138.97 | $161.16 | $206.64 | 0% | Neutral | |
| $145.84 | $181.24 | $237.29 | +12% | Neutral | |
| $168.20 | $214.17 | $289.87 | +33% | Bullish | |
| $183.48 | $238.36 | $331.12 | +48% | Bullish | |
| $178.72 | $236.33 | $335.59 | +47% | Bullish | |
| $182.06 | $244.65 | $354.15 | +52% | Bullish | |
| $188.55 | $257.18 | $378.77 | +60% | Bullish | |
| $197.61 | $273.34 | $408.93 | +70% | Bullish | |
| $224.86 | $315.17 | $478.37 | +96% | Bullish | |
| $242.63 | $344.41 | $529.82 | +114% | Bullish | |
| $298.65 | $448.84 | $730.55 | +179% | Bullish | |
| $487.09 | $806.48 | $1,425.92 | +400% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $138.97 | $161.16 | $190.68 | +0.00% |
| August 2026 | $138.44 | $162.91 | $196.51 | +1.09% |
| September 2026 | $141.95 | $168.07 | $204.73 | +3.17% |
| October 2026 | $140.21 | $166.89 | $204.99 | -0.70% |
| November 2026 | $136.66 | $163.39 | $202.09 | -2.10% |
| December 2026 | $138.27 | $166.01 | $206.64 | +1.60% |
Click any year to see its month-by-month PODD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PODD could reach as high as $206.64, with a base case around $161.16 and support toward $138.97 — roughly 0% from $161.16. Price action looks broadly range-bound.
Expect PODD to range from $145.84 to $237.29 through 2027. The $181.24 average target implies a +12% move from current prices. That is up +12% on the projected 2026 average. A consolidation phase looks the most probable path here.
The PODD price prediction for 2028 points to an average of $214.17 (low $168.20, high $289.87) — a potential gain of +33% on today's $161.16. Momentum favours further upside here.
In 2029, PODD is projected to trade between $183.48 and $331.12, averaging $238.36 — a potential gain of +48% from today's $161.16. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Insulet Corporation's 2030 outlook centres on $236.33, within a $178.72 to $335.59 range. That is -1% versus the projected 2029 average. That marks a +47% change versus current levels. Momentum favours further upside here.
By 2031, PODD could reach as high as $354.15, with a base case around $244.65 and support toward $182.06 — roughly +52% from $161.16. Buyers look set to stay in control over this stretch.
Expect PODD to range from $188.55 to $378.77 through 2032. The $257.18 average target implies a +60% move from current prices. That is up +5% on the projected 2031 average. Momentum favours further upside here.
The PODD price prediction for 2033 points to an average of $273.34 (low $197.61, high $408.93) — a potential gain of +70% on today's $161.16. Buyers look set to stay in control over this stretch.
In 2034, PODD is projected to trade between $224.86 and $478.37, averaging $315.17 — a potential gain of +96% from today's $161.16. That is up +15% on the projected 2033 average. Momentum favours further upside here.
Insulet Corporation's 2035 outlook centres on $344.41, within a $242.63 to $529.82 range. That is up +9% on the projected 2034 average. That marks a +114% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, PODD could reach as high as $730.55, with a base case around $448.84 and support toward $298.65 — roughly +179% from $161.16. Momentum favours further upside here.
Expect PODD to range from $487.09 to $1,425.92 through 2050. The $806.48 average target implies a +400% move from current prices. That is up +80% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PODD today (≈ 6.205206 PODD) could be worth
$5,004.39
+$4,004.39 (+400%) by 2050 · US Dollar
Based on the average projected PODD price of $806.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PODDwould be worth at today's price.
$1,000 invested in PODD on Jul 10, 2025 (≈ 3.362475 PODD) would be worth
$541.88
-$458.12 (-45.8%) today · 0.54× · US Dollar
Based on a PODD entry price of $297.4 vs. today's $161.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $164.48 | $979.78 | -2.0% |
| 1 month ago | $150.71 | $1,069.31 | +6.9% |
| 3 months ago | $196.93 | $818.34 | -18.2% |
| 6 months ago | $278.55 | $578.55 | -42.1% |
| 1 year ago | $297.4 | $541.88 | -45.8% |
| All time (5.0y) ago | $275.64 | $584.66 | -41.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PODD forecast.
Our base-case forecast reaches $320.00 around 2035.
Implied market cap at $320.00: $22.16B
The multi-year forecast shows a neutral path in 2026, with an average of $159.79 and ROI of 0%. The outlook turns bullish in subsequent years, with 2027 average $179.85 (ROI 12.6%), 2028 average $214.38 (ROI 34.2%), and 2029 average $240.74 (ROI 50.7%), then 2030 avg $233.42 (ROI 46.1%) and a growing bullish trend through 2035 (2031 avg $242.58, ROI 51.8%; 2032 avg $257.53, ROI 61.2%; 2033 avg $267.66, ROI 67.5%; 2034 avg $314.16, ROI 96.6%; 2035 avg $347.88, ROI 117.7%). The forecast continues bullish in 2040 at avg $448.48 (ROI 180.7%) and reaches 2050 at avg $803.09 (ROI 402.6%), with max values shown as $337.68 (2030), $751.00 (2040), and $1,468.70 (2050).
These are estimates, not guarantees, and reflect potential upside under the provided numbers.
Tap a question to reveal the answer.
2030 min $173.80, avg $233.42, max $337.68; ROI 46.1%; sentiment BULLISH.
Forecasts show neutral in 2026 (avg $159.79; ROI 0) and 2027 (avg $179.85; ROI 12.6), then bullish with higher averages and ROIs through 2050 (e.g., 2040 avg $448.48; ROI 180.7%; 2050 avg $803.09; ROI 402.6%). These are estimates, not guarantees.
Yes—the max forecast for 2050 is $1,468.70, while the 2050 average is $803.09 and the 2040 max is $751.00.
Current price is $159.79 and market cap is $11.07B.
30-day range low is $134.17 and high is $190.30.
Insulet Corporation Community Discussion
0Share your Insulet Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.